MPAM
BIO icon

Monarch Partners Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Monarch Partners Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-678
Closed -$238K – 174
2020
Q1 		$238K Buy
+678
New +$249K 0.08% 146
2019
Q1 		– Sell
-10,603
Closed -$2.46M – 173
2018
Q4 		$2.46M Sell
10,603
-21,999
-67% -$5.9M 0.36% 75
2018
Q3 		$10.2M Sell
32,602
-16,451
-34% -$5.11M 0.93% 43
2018
Q2 		$14.2M Sell
49,053
-22,370
-31% -$6.18M 1.28% 21
2018
Q1 		$17.9M Buy
+71,423
New +$18.2M 1.66% 7

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Monarch Partners Asset Management's BIO Position: Q2 2020 in Review

Monarch Partners Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 678 shares — an estimated $238K sold.

Monarch Partners Asset Management first reported a position in BIO in Q1 2018 and held it in 5 quarters. The position peaked at $17.9M in Q1 2018. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Monarch Partners Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Monarch Partners Asset Management sold 678 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $238K.
  • Monarch Partners Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 5 quarters.
  • Monarch Partners Asset Management's Bio-Rad Laboratories Class A position peaked at $17.9M in Q1 2018.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Monarch Partners Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.